Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 22, 1987 - Issue 7
Submit an article Journal homepage
52
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Mesalazine Tolerance in Patients with Inflammatory Bowel Disease and Previous Intolerance or Allergy to Sulphasalazine or Sulphonamides

U. Turunen The Second Dept. of Internal Medicine and Dept. of Clinical Chemistry, University Central Hospital, Helsinki
,
I. Elomaa The Second Dept. of Internal Medicine and Dept. of Clinical Chemistry, University Central Hospital, Helsinki
,
V.-J. Anttila The Second Dept. of Internal Medicine and Dept. of Clinical Chemistry, University Central Hospital, Helsinki
&
K. Seppälä Dept. of Medicine, Central Hospital, Jyväskylä., Finland
Pages 798-802 | Received 10 Nov 1986, Accepted 06 Mar 1987, Published online: 08 Jul 2009

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dorien J. Buurman, Jan G.R. De Monchy, Reinout C.A. Schellekens, Laurens A. van der Waaij, Jan H. Kleibeuker & Gerard Dijkstra. (2015) Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study. Scandinavian Journal of Gastroenterology 50:4, pages 399-405.
Read now

Articles from other publishers (40)

Ishrat Mansuri, Sophia Wang, Paul A. Rufo, Enju Liu, Christina Chan & Athos Bousvaros. (2022) Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis. Journal of Pediatric Gastroenterology & Nutrition 76:4, pages 460-467.
Crossref
Sean Hammond, Anna Olsson-Brown, Sophie Grice, Andrew Gibson, Joshua Gardner, Jose Luis Castrejón-Flores, Carol Jolly, Benjamin Alexis Fisher, Neil Steven, Catherine Betts, Munir Pirmohamed, Xiaoli Meng & Dean John Naisbitt. (2022) Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. Toxicological Sciences 186:1, pages 58-69.
Crossref
Isabel Garrido, Ana Luísa Santos, Joanne Lopes, Susana Lopes & Guilherme Macedo. (2021) “Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug”. European Journal of Gastroenterology & Hepatology 33:1S, pages e1067-e1070.
Crossref
Manja Newe, Theresa A. Kant, Maximilian Hoffmann, Johanna S. E. Rausch, Luise Winter, Karolina Künzel, Erik Klapproth, Claudia Günther & Stephan R. Künzel. (2021) Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice. Naunyn-Schmiedeberg's Archives of Pharmacology 394:11, pages 2233-2244.
Crossref
Siddharth Singh, Joseph D. Feuerstein, David G. Binion & William J. Tremaine. (2019) AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 156:3, pages 769-808.e29.
Crossref
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa & Angelo Viscido. (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 49:4, pages 338-358.
Crossref
Reena Khanna & John K. Marshall. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 389 397 .
Rim Atheymen, Hanen Affes, Kamilia Ksouda, Leila Mnif, Zouheir Sahnoun, Nabil Tahri, Khaled Mounir Zeghal & Serria Hammami. (2013) Effets indésirables de la sulfasalazine : discussion de leur mécanisme et du rôle de la composante sulfamidée. Therapies 68:6, pages 369-373.
Crossref
Brian G Feagan & John K MacDonald. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Reena Khanna & John K. Marshall. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 453 466 .
Brian T. Fowler, Tina Gupta & Muhammad Bilal. (2010) Asacol®-induced Neutropenia Resolution Without the Use of Granulocyte Colony-stimulating Factor. Southern Medical Journal 103:11, pages 1167-1169.
Crossref
Ari Wiesen, Jonathan Wiesen, Sewanti Limaye & Neeraj Kaushik. (2009) Mesalazine-Induced Aplastic Anemia. The American Journal of Gastroenterology 104:4, pages 1063-1063.
Crossref
Shiang-Ju Kung, Cuckoo Choudhary, Stephen J. McGeady & John R. Cohn. (2006) Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature. Annals of Allergy, Asthma & Immunology 97:3, pages 284-287.
Crossref
Lloyd R Sutherland & John K MacDonald. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ioannis Paraskevopoulos, George Konstantinou & Christos Liatsos. (2005) Desensitization Treatment of An Aspirin- and Mesalamine-Sensitive Patient With Crohnʼs Disease. Inflammatory Bowel Diseases 11:4, pages 417-419.
Crossref
Craig A Solem & Edward V LoftusJr.Jr.. (2004) Management of refractory inflammatory bowel disease. Gastroenterology Clinics of North America 33:2, pages 319-334.
Crossref
L Sutherland & JK MacDonald. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Johanna C. Escher, Jan A. J. M. Taminiau, Edward E. S. Nieuwenhuis, Hans A. Büller & Richard J. Grand. (2003) Treatment of Inflammatory Bowel Disease in Childhood: Best Available Evidence. Inflammatory Bowel Diseases 9:1, pages 34-58.
Crossref
S. Varela, M.S Díez, C. Gonzalez, C. Gonzalez de la Cuesta, L. Arenas, R. Feijoó & M. Menéndez. (2002) Oral desensitization to 5‐ASA. Allergy 57:4, pages 371-372.
Crossref
Elizaveta Iofel, Anupama Chawla, Fredric Daum & James Markowitz. (2002) Mesalamine Intolerance Mimics Symptoms of Active Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 34:1, pages 73-76.
Crossref
M.C. Di Paolo, O.A. Paoluzi, R. Pica, F. Iacopini, P. Crispino, M. Rivera, G. Spera & P. Paoluzi. (2001) Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Digestive and Liver Disease 33:7, pages 563-569.
Crossref
Roongroj Bhidayasiri, Jeffry A. Katz & Denise R. Sokos. (2000) Correction of mesalazine-induced neutropenia with high dose G-CSF. The American Journal of Gastroenterology 95:11, pages 3321-3322.
Crossref
Richard J Farrell, Mark A Peppercorn, Steven N Fine & Pierre Michetti. (1999) Mesalamine-Associated Thrombocytopenia. American Journal of Gastroenterology 94:8, pages 2304-2306.
Crossref
A Lachaux, C Le Gall, I Loras-Duclaux, A Aboufadel & M Hermier. (1997) Hypersensibilité à l'acide 5-aminosalicylique. Intérêt de la désensibilisation par voie orale. Archives de Pédiatrie 4:2, pages 144-146.
Crossref
Bodo Stoschus, Monika Meybehm, Ulrich Spengler, Christian Scheurlen & Tilman Sauerbruch. (1997) Cholestasis associated with mesalazine therapy in a patient with Crohn's disease. Journal of Hepatology 26:2, pages 425-428.
Crossref
Lloyd R. Sutherland, Daniel E. Roth & Paul L. Beck. (1997) Alternatives to Sulfasalazine: A Meta-analysis of 5-ASA in the Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases 3:2, pages 65-78.
Crossref
F. Casellas, A. Vallano & J. R. Malagelada. (1996) Leukopenia and Thrombocytopenia as Adverse Effects of Treatment with 5-Aminosalicylic Suppositories. Journal of Clinical Gastroenterology 22:2, pages 160-161.
Crossref
John B. Sturgeon, Paramjit Bhatia, Donald Hermens & Philip B. MinerJr.Jr.. (1995) Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology 108:6, pages 1889-1893.
Crossref
Corrado Brignola, Mario Cottone, Angelo Pera, Sandro Ardizzone, Maria Lia Scribano, Roberto de Franchis, Agesilao D'Arienzo, Giuseppe D'Albasio & Daniele Pennestri. (1995) Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 108:2, pages 345-349.
Crossref
S. Wyatt, M.V. Joyner & T.K. Daneshmend. (1993) Filgrastim for mesalazine-associated neutropenia. The Lancet 341:8858, pages 1476.
Crossref
Marc L. Hautekeete, Nadine Bourgeois, Philippe Potvin, Lieve Duville, Hendrik Reynaert, Ghislain Devis, Michael Adler & Günter Klöppel. (1992) Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 103:6, pages 1925-1927.
Crossref
M. H. GIAFFER, C. J. O'BRIEN & C. D. HOLDSWORTH. (2007) Clinical tolerance to three 5‐aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine. Alimentary Pharmacology & Therapeutics 6:1, pages 51-59.
Crossref
A. B. R. THOMSON. (2007) Review article: new developments in the use of 5‐aminosalicylic acid in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 5:5, pages 449-470.
Crossref
T.K. Daneshmend. (1991) Mesalazine-associated thrombocytopenia. The Lancet 337:8752, pages 1297-1298.
Crossref
Jill Mancini Fitzgerald & T. Donald Marsh. (2016) Mesalamine in Ulcerative Colitis. DICP 25:2, pages 140-145.
Crossref
A. B. R. Thomson. 1990. Inflammatory Bowel Diseases 1990. Inflammatory Bowel Diseases 1990 179 211 .
Malcolm G. Robinson. (1989) New Oral Salicylates in the Therapy of Chronic Idiopathic Inflammatory Bowel Disease. Gastroenterology Clinics of North America 18:1, pages 43-50.
Crossref
Kiron M. Das. (1989) Sulfasalazine Therapy in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 18:1, pages 1-20.
Crossref
M.N.G. Dukes. 1989. 328 342 .
U. Klotz. 1989. Clinical Research in Gastroenterology 2. Clinical Research in Gastroenterology 2 17 30 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.